Coordinating transcranial magnetic stimulation (TMS) with ketamine therapy shows promising potential for patients with treatment-resistant depression, combining the rapid relief of ketamine with the long-term durability of TMS. While ketamine acts quickly to alleviate acute symptoms, its effects are often short-lived unless treatment is ongoing. Deep TMS, by contrast, builds more gradual but sustained improvements over weeks, often maintaining remission for months. Emerging evidence suggests that sequencing these treatments — starting with ketamine for immediate relief and following with Deep TMS for lasting outcomes — can offer additive benefits without diminishing effectiveness, though more research is needed to fully understand their combined impact.
Key Takeaways:
Rapid + Durable Relief: Ketamine provides fast-acting symptom relief, while Deep TMS delivers sustained response and remission.
Complementary Mechanisms: Both therapies influence glutamate and AMPA channels, potentially priming one another for enhanced outcomes.
Sequential Use Recommended: Most clinicians start with ketamine for acute cases and transition to Deep TMS for long-term stability.
Growing Field: Coordinated treatment is gaining traction under the umbrella of interventional psychiatry, expanding non-pharmaceutical options.
Future Focus: Further randomized trials are needed, but early studies show combined therapy is at least as effective as Deep TMS alone.
